Abstract
The aim of this study is to explore the clinical characteristic and the diagnostic role of MG7-Ag in detecting gastric cancer (GC) through a systematic review and meta-analysis. Relevant manuscripts aiming at the application of serum MG7-Ag level in GC diagnosis were searched in PubMed, Embase, Chinese National Knowledge Infrastructure, VIP, and Wan Fang Data independently, which were published between January 1, 1980 and February 28, 2013. The pooled sensitivity, specificity, positive diagnostic likelihood ratio (DLR+), negative diagnostic likelihood ratio (DLR−), diagnostic odds ratio, and the area under the summary receiver operating characteristic (AUC) were used to evaluate the value of serum MG7-Ag in diagnosis of GC by using the Meta-DiSc and STATA 11.0 statistical software. 410 manuscripts were retrieved, and 7 manuscripts of high quality including 652 patients were of high quality in this meta-analysis. Overall, the pooled sensitivity, specificity, DLR+, DLR−, and AUC were 0.73 (95 % CI 0.63–0.82), 0.91 (95 % CI 0.84–0.94), 8.59 (95 % CI 5.62–13.11), 0.29 (95 % CI 0.21–0.42), and 0.92 (95 % CI 0.89–0.94), respectively. MG7-Ag is a potential biomarker for the diagnosis of GC. However, more studies are needed to confirm the standard criteria.
Similar content being viewed by others
References
Miki K (2006) Gastric cancer screening using the serum pepsinogen test method. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 9:245–253
Chen W, Zheng R, Zhang S et al (2013) Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res 25:10
Shi Y, Hu W, Yin F et al (2004) Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 7:160–166
Wu WK, Lee CW, Cho CH et al (2010) MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29:5761–5771
Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257–2261
Lee JH, Son SY, Lee CM, Ahn SH, Park DJ, Kim HH (2013) Morbidity and mortality after laparoscopic gastrectomy for advanced gastric cancer: results of a phase II clinical trial. Surgical endoscopy
Liu D, Zhang L, Shen Z, et al. (2013) Increased levels of SLP-2 correlate with poor prognosis in gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Hanazaki K, Sodeyama H, Yokoyama S et al (1998) Postoperative chemotherapy may improve prognosis in unresectable gastric cancer. J Clin Gastroenterol 26:269–273
Nashimoto A, Nakajima T, Furukawa H et al (2003) Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206–1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 21:2282–2287
Jeong SH, Bae K, Ha CY et al (2013) Effectiveness of endoscopic clipping and computed tomography gastroscopy for the preoperative localization of gastric cancer. J Korean Surg Soc 84:80–87
Tajiri H, Doi T, Endo H et al (2002) Routine endoscopy using a magnifying endoscope for gastric cancer diagnosis. Endoscopy 34:772
Takahashi Y, Takeuchi T, Sakamoto J et al (2003) The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 6:142–145
Jin B, Wang X, Jin Y et al (2009) Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method. Cancer Invest 27:227–233
Ren J, Chen Z, Juan SJ, Yong XY, Pan BR, Fan DM (2000) Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique. Cancer 88:280–285
Fang X, Tie J, Xie Y, Li Q, Zhao Q, Fan D (2010) Detection of gastric carcinoma-associated antigen MG7-Ag in human sera using surface plasmon resonance sensor. Cancer epidemiol 34:648–651
Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25
Walter S (2002) Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21:1237–1256
Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31
Liu J (1999) Serum MG7-Ag and TAG-72 in the diagnosis of gastric cancer. ShenZhen Medical Journal 12
Li XH, Song BH, Li CL, Hu JL (1996) The diagnostic significance of serum tumor markers MG7-Ag in the gastric cancer. Journal Of The Fourth Military medical university: 75–7
Wang YL, Yao XH, Lou GC. Clinical significance of determination of five tumor markers in the peripheral blood of patients with gastric cancer. Journal Of HangZhou Normal University 2006:242-4 + 7
Jin GY, Meng C, Jiang JT, Deng H. The diagnostic value of serum MG7-Ag, CA19-9 and IAP joint detection of gastric cancer. Journal of SuZhou Medical University 2001:72-3
Wang MS. Combined detection of serum OPN, MG7-Ag, TPS diagnostic value of gastric cancer. Shandong Medical Journal 2011;51
Zhang L, Ren J, Pan K et al (2010) Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening. Int J 1) 126:469–473
DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemporary clinical trials 28:105–114
Group UCSW (2013) United States Cancer Statistics: 1999–2009 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: a cancer journal for clinicians
Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425
Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M (1995) Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587
Pectasides D, Mylonakis A, Kostopoulou M et al (1997) CEA, CA 19–9, and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol 20:348–353
Wobbes T, Thomas C, Segers M, Nagengast F (2006) Evaluation of seven tumor markers (CA 50, CA 19–9, CA 19–9 TruQuant, CA 72–4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma. Cancer 69:2036–2041
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135
AS R, Korsten M (2007) Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing. Advances in medical sciences 52
Jones CM, Athanasiou T (2005) Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 79:16
Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J (2004) Rectal Cancer: local Staging and Assessment of Lymph Node Involvement with Endoluminal US, CT, and MR Imaging—A Meta-Analysis1. Radiology 232:773–783
Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Acknowledgments
We thank Dr. Manran Liu for the scientific design.
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Zongyue Zeng and Sheng Fu contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zeng, Z., Fu, S., Hu, P. et al. The diagnostic value of monoclonal gastric cancer 7 antigen: a systematic review with meta-analysis. Clin Exp Med 14, 337–343 (2014). https://doi.org/10.1007/s10238-013-0246-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-013-0246-5